Hera Health Solutions

Hera Health Solutions is a biotechnology and pharmaceutical device company that specializes in a proprietary nanotechnology-enabled drug delivery platform. The company utilizes bioerodible nanofiber scaffolds, manufactured through an electrospinning process, to reformulate existing active pharmaceutical ingredients into long-acting formats such as implants, patches, and pellets. This technology allows for the controlled release of medications into the body over extended durations ranging from days to years, offering a platform designed to increase therapeutic efficacy and improve patient convenience. Its lead product currently under development is Eucontra, a long-acting biodegradable contraceptive implant.

The company serves as a collaborator for global pharmaceutical partners, providing licensing opportunities to help companies extend treatment durations and unlock new therapeutic applications for existing drugs. By focusing on scalable design and long-acting delivery systems, Hera Health Solutions addresses challenges related to treatment adherence, efficacy, and side-effect profiles. Based in Memphis, Tennessee, and founded in 2017, the company has secured various forms of investment and engaged in international licensing agreements to expand the application of its platform across different therapeutic areas and markets.